This study evaluates the effect in chronic migraine patients of daily 20 minute-transcutaneous sub occipital neurostimulation using the occipital Cefaly° device.
Chronic migraine is a disabling neurological condition affecting 0.5-2% of the population. CM is difficult to treat and preventive treatment options are limited. Due to the inefficiency of available and the lack of new preventive anti-migraine drug, neurostimulation methods have raised great interest in recent years. The ONSTIM study showed a reduction in headache frequency in 39% of patients treated with active ONS during 12 weeks, compared to no improvement in the "non-effectively" stimulated or medically treated groups.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Occipital neurostimulation can have a therapeutic effect in chronic migraine treatment, thus representing a possible therapeutic option in patients that do not respond to any medication.
CHR Citadelle
Liège, Belgium, Belgium
RECRUITINGMonthly frequency of migraine days
Time frame: 2 months treatment
Monthly frequency of headache days
Time frame: 2 months
Monthly frequency of total headache days
Time frame: 2 months
Cumulative monthly headache hours
Time frame: 2 months
Monthly acute drug intake
Time frame: 2 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.